U
USNA icon

UBS’s Usana Health Sciences USNA Stock Holding History

UBS’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-800
Closed -$29K – 10736
2013
Q2 		$29K Buy
+800
New +$24.3K ﹤0.01% 7432

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's USNA Position: Q3 2014 in Review

UBS reduced its Usana Health Sciences (USNA) stake by 69% in Q3 2014, selling an estimated $307K and leaving 3,902 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5541.

UBS first reported a position in USNA in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.69M in Q1 2014. 124 funds tracked by Wall St. Rank hold USNA as of Q3 2014.

  • UBS held 3,902 shares of Usana Health Sciences worth $144K as of Q3 2014.
  • UBS sold 8,494 Usana Health Sciences shares in Q3 2014, an estimated $307K.
  • Usana Health Sciences made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5541 holding.
  • UBS first reported a position in Usana Health Sciences in Q2 2013 and has held it in 6 quarters since.
  • UBS's Usana Health Sciences position peaked at $3.69M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.